New Jersey S 1775: Requires Medicaid preferred drug lists to provide for coverage of buprenorphine for treatment of chronic pain.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-02-13)

State: New Jersey · Session: 219 · Bill: S 1775

Subjects: MEDICAID, PHARMACEUTIC

Sponsors: Madden, Fred H.

View New Jersey S 1775 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.